Skip to main content

Over 150 LLM Providers · Over 5,300 Models The most extensible AI-powered pentesting platform. Open source. Star on GitHub

CVE-2011-3386

4.0 · MEDIUM
Published Sep 2, 2011 medtronic EPSS 1.45% (72th pctl)

Overview

CVE-2011-3386 is a medium-severity vulnerability affecting medtronic paradigm_wireless_insulin_pump. It was published on September 2, 2011 and has a CVSS 2.0 base score of 4.0 (MEDIUM).

This vulnerability has a CVSS 2.0 base score of 4.0, rated MEDIUM. It can be exploited remotely over the network. No authentication or special privileges are required for exploitation.

Technical Description

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."

Remediation

Check the references section for vendor advisories and patches from medtronic. Update paradigm_wireless_insulin_pump to the latest patched version. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Affected Products

Vendor Product Versions Status

Frequently Asked Questions

What is CVE-2011-3386?

CVE-2011-3386 is a medium-severity vulnerability affecting medtronic paradigm_wireless_insulin_pump. It was published on September 2, 2011 and has a CVSS 2.0 base score of 4.0 (MEDIUM).

How severe is CVE-2011-3386?

This vulnerability has a CVSS 2.0 base score of 4.0, rated MEDIUM. It can be exploited remotely over the network. No authentication or special privileges are required for exploitation.

How do I fix or remediate CVE-2011-3386?

Check the references section for vendor advisories and patches from medtronic. Update paradigm_wireless_insulin_pump to the latest patched version. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2011-3386?

CyberStrike's AI-powered security agents can automatically detect CVE-2011-3386 across your infrastructure using autonomous pentesting, DAST scanning, and HackBrowser. The platform continuously monitors for known vulnerabilities and provides actionable remediation guidance prioritized by real-world exploitability.